Lista de obras - Adela Cañete - Dominio Público Uruguay

1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors

artículo científico publicado en 2017

A comparison of current neuroblastoma chemotherapeutics

artículo científico publicado en 2004

A novel TP53 germ-line mutation identified in a girl with a primitive neuroectodermal tumor and her father.

artículo científico publicado en 1998

Advances in emerging drugs for the treatment of neuroblastoma

artículo científico publicado en 2017

Allogeneic PBPC transplantation in children

Analysis of biological prognostic factors using tissue microarrays in neuroblastic tumors

article

Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients

artículo científico publicado en 2000

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

artículo científico publicado en 1998

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival

artículo científico publicado en 1994

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.

artículo científico publicado en 2017

Cancer in children and adolescents in Spain: incidence, treatment setting and provider specialty

artículo científico publicado en 2015

Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

artículo científico publicado en 2015

Congenital fibrosarcoma simulating congenital hemangioma

scientific article published on 01 January 2008

Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.

artículo científico publicado en 2017

El nuevo reto en oncología: la secuenciación NGS y su aplicación a la medicina de precisión

scientific article published on 24 June 2016

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients.

artículo científico publicado en 2010

Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1

scientific article published on 20 December 2010

Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification

artículo científico publicado en 2009

Gammagrafía ósea y gammagrafía de receptores de la somatostatina en pacientes pediátricos con histiocitosis de células de Langerhans ósea

scientific article published on 01 November 2003

HG-128BO25041 - A PHASE II OPEN-LABEL, RANDOMIZED, MULTI CENTRE COMPARATIVE STUDY OF BEVACIZUMAB BASED THERAPY IN PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED SUPRATENTORIAL, INFRATENTORIAL CEREBELLAR, OR PEDUNCULAR HIGH GRADE GLIOMA.

artículo científico publicado en 2016

HG-85INTER-OBSERVER AGREEMENT IN NEUROPATHOLOGICAL HGG DIAGNOSIS : EXPERIENCE OF THE PRE-RANDOMISATION CENTRAL REVIEW IN THE HERBY TRIAL.

artículo científico publicado en 2016

Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.

artículo científico publicado en 2001

How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma

artículo científico publicado en 2011

Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease

article

Immunohistochemical evaluation of a novel clone of monoclonal anti-MYCN antibody B8.4B in neuroblastic tumours: a correlation with MYCN gene status

artículo científico publicado en 2006

Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma

artículo científico publicado en 2016

Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

artículo científico publicado en 1998

Landscape of early clinical trials for childhood and adolescence cancer in Spain

article

Long-term results of high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma patients: a report of the Spanish working party for BMT in children (Getmon).

artículo científico publicado en 2004

MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors

artículo científico publicado en 2008

MYCN gain and MYCN amplification in a stage 4S neuroblastoma

artículo científico publicado en 2003

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

artículo científico publicado en 1995

Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.

artículo científico publicado en 2017

Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?

artículo científico publicado en 2016

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

artículo científico publicado en 2011

Minimal residual disease in neuroblastoma: to GAGE or not to GAGE.

artículo científico publicado en 2004

Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience

scientific article published on 01 July 2015

Neuroblastoma

artículo científico publicado en 2005

Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration

artículo científico publicado en 2014

Neuroblastoma in adolescents: genetic and clinical characterisation

New prognostic markers in neuroblastoma.

artículo científico

Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.

artículo científico publicado en 2001

PNR-16DIAGNOSIS, MANAGEMENT AND OUTCOME OF CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) PRIMITIVE NEUROECTODERMAL TUMORS (PNET) IN SPAIN: A STUDY FROM THE SPANISH NATIONAL PEDIATRIC ONCOLOGY & HEMATOLOGY SOCIETY (SEHOP).

artículo científico publicado en 2016

Paediatric tumour boards in Spain: a national survey

artículo científico

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

artículo científico publicado en 2013

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.

artículo científico publicado en 2018

Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience

artículo científico publicado en 2016

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

artículo científico publicado en 2009

Presentation and Long-term Outcome of High-grade Osteosarcoma

Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content

artículo científico publicado en 2011

Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.

artículo científico publicado en 1999

Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors

scientific article published on 01 May 1995

Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma

artículo científico publicado en 2000

Retained intravascular fragments after removal of indwelling central venous catheters: a single institution experience

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

artículo científico publicado en 2011

Solid ovarian tumours in childhood: a 35-year review in a single institution.

artículo científico publicado en 2010

Subtelomeric analysis of pediatric astrocytoma: subchromosomal instability is a distinctive feature of pleomorphic xanthoastrocytoma.

artículo científico publicado en 2008

Surgical treatment for neuroblastoma: Complications during 15 years' experience

artículo científico publicado en 1998

Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project.

artículo científico publicado en 2018

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients

artículo científico publicado en 2015

TIAM1 variants improve clinical outcome in neuroblastoma

artículo científico publicado en 2017

Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor

artículo científico publicado en 2013

The doublecortin gene, a new molecular marker to detect minimal residual disease in neuroblastoma

artículo científico publicado en 2005

The role of surgery in stage IV neuroblastoma.

artículo científico publicado en 2002

Treatment of high-risk neuroblastoma with anti-GD2 antibodies

artículo científico publicado en 2010

Tumour banks in pediatric oncology

artículo científico publicado en 2006

Two independent epigenetic biomarkers predict survival in neuroblastoma

artículo científico publicado en 2015

Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma

artículo científico publicado en 2001

[Early clinical trials in paediatric oncology in Spain: a nationwide perspective].

artículo científico publicado en 2017

[Solid ovarian tumors in childhood]

artículo científico publicado en 1997

miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis ⬇️

artículo científico publicado en 2016

Lista de obras de Adela Cañete

1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors

A comparison of current neuroblastoma chemotherapeutics

A novel TP53 germ-line mutation identified in a girl with a primitive neuroectodermal tumor and her father.

Advances in emerging drugs for the treatment of neuroblastoma

Allogeneic PBPC transplantation in children

Analysis of biological prognostic factors using tissue microarrays in neuroblastic tumors

Angiogenesis in neuroblastoma: relationship to survival and other prognostic factors in a cohort of neuroblastoma patients

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.

Cancer in children and adolescents in Spain: incidence, treatment setting and provider specialty

Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors

Congenital fibrosarcoma simulating congenital hemangioma

Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.

El nuevo reto en oncología: la secuenciación NGS y su aplicación a la medicina de precisión

Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients.

Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1

Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification

Gammagrafía ósea y gammagrafía de receptores de la somatostatina en pacientes pediátricos con histiocitosis de células de Langerhans ósea

HG-128BO25041 - A PHASE II OPEN-LABEL, RANDOMIZED, MULTI CENTRE COMPARATIVE STUDY OF BEVACIZUMAB BASED THERAPY IN PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED SUPRATENTORIAL, INFRATENTORIAL CEREBELLAR, OR PEDUNCULAR HIGH GRADE GLIOMA.

HG-85INTER-OBSERVER AGREEMENT IN NEUROPATHOLOGICAL HGG DIAGNOSIS : EXPERIENCE OF THE PRE-RANDOMISATION CENTRAL REVIEW IN THE HERBY TRIAL.

Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.

How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma

Hypermethylation of apoptotic genes as independent prognostic factor in neuroblastoma disease

Immunohistochemical evaluation of a novel clone of monoclonal anti-MYCN antibody B8.4B in neuroblastic tumours: a correlation with MYCN gene status

Immunoproteomic studies on paediatric opsoclonus-myoclonus associated with neuroblastoma

Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

Landscape of early clinical trials for childhood and adolescence cancer in Spain

Long-term results of high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma patients: a report of the Spanish working party for BMT in children (Getmon).

MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors

MYCN gain and MYCN amplification in a stage 4S neuroblastoma

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.

Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

Minimal residual disease in neuroblastoma: to GAGE or not to GAGE.

Multimodality Treatment of Pediatric and Adult Patients With Ewing Sarcoma: A Single-institution Experience

Neuroblastoma

Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration

Neuroblastoma in adolescents: genetic and clinical characterisation

New prognostic markers in neuroblastoma.

Outcome of high-risk neuroblastoma using a dose intensity approach: improvement in initial but not in long-term results.

PNR-16DIAGNOSIS, MANAGEMENT AND OUTCOME OF CHILDREN WITH CENTRAL NERVOUS SYSTEM (CNS) PRIMITIVE NEUROECTODERMAL TUMORS (PNET) IN SPAIN: A STUDY FROM THE SPANISH NATIONAL PEDIATRIC ONCOLOGY & HEMATOLOGY SOCIETY (SEHOP).

Paediatric tumour boards in Spain: a national survey

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.

Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Presentation and Long-term Outcome of High-grade Osteosarcoma

Prognostic value of partial genetic instability in neuroblastoma with ≤50% neuroblastic cell content

Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.

Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors

Results of the cooperative protocol (N-III-95) for metastatic relapses and refractory neuroblastoma

Retained intravascular fragments after removal of indwelling central venous catheters: a single institution experience

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Solid ovarian tumours in childhood: a 35-year review in a single institution.

Subtelomeric analysis of pediatric astrocytoma: subchromosomal instability is a distinctive feature of pleomorphic xanthoastrocytoma.

Surgical treatment for neuroblastoma: Complications during 15 years' experience

Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project.

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients

TIAM1 variants improve clinical outcome in neuroblastoma

Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor

The doublecortin gene, a new molecular marker to detect minimal residual disease in neuroblastoma

The role of surgery in stage IV neuroblastoma.

Treatment of high-risk neuroblastoma with anti-GD2 antibodies

Tumour banks in pediatric oncology

Two independent epigenetic biomarkers predict survival in neuroblastoma

Value of 123I-MIBG scanning, neuron-specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma

[Early clinical trials in paediatric oncology in Spain: a nationwide perspective].

[Solid ovarian tumors in childhood]

miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis ⬇️